VDRM MUCH HIGHER PART 3 - NEWS WITH RESULTS
So far though, this has been one heck of a good stock and a pleasant ride.
IM still on the train and watching many enter and exit, reading about dreams of final destinations and those who got off and can't find another stop to get back on, some even wanting their seats back from where they got on the VDRM train. the train slows down and stops at times and then I get to read about the bumps and bruises, read of those who have exited and wish to share their story and those like me who are excited to be on board.
As i've said in previous posts im long alot of stock here, trading a drop but buying more on stops..the analysis by myself and other intelligent parties should be read and should be followed and understood as we are giving you the research to appreciate the Who, Why, What, How on the VDRM future...re read my posts from past with targets on where we will go..
Here is the 3rd Part of my analysis:
So all really understand and appreciate what is truly happening here. The history as i see it is that Phillips Tetracycline Topical Ointment/ Tetratsem is a manufactured product last time done was 2.25.2014 with assuming a shelf life of 3 years
VIADERMA manufacturing started 5.28.2014 with a shelf life of 3 years
On 3.2014 patent from philips was files
On 6.2014 patent exclusivity to VDRM starts
Articles :
1.4.2017 philips article from 2.25.2011 with 3 year shelf life estimate
3.2.2015 Nychomycosis
11.8.2016 Viabecline
12.1.2016 Diabetic Ulcers
12.14.2016 Viabecline patent filed for applied by VDRM
History:
TETRASTEM is owned by Philips is an ointment
VIABECLINE is owned by Viaderma is a deliver system
2017 VDRM:
1) Exclusivity of Philips patent to manufacture of Tetrastem granted to Viaderma
2) Viaderma patemt of application of Tetrastem filed for
3) Viaderma patent of Viabecline filed for
Applications:
stem cells parapalegics ( article done read it !! )
diabeties
acne
psorasis
eczema
antifungal drugs
staph infections ( hospital cream - huge !! )
topical antibiotics
To sum it all up as others and myself are steering the ship with guiding all to the land of success, Viaderma tested Philips product and improved on it , decided to license exclusively for it with Philips getting a royalty on each sold product, took the next step and applied for patent against all uses of Tetrastem Ointment, and than said why stop there , Viabecline patent applied for entire body and time any where any way, so basically you want to use Tetrastem ... viaderma gets paid and pays philips a piece, you want to apply it anywhere in the body Viaderma gets payed and pays nothing to philips...
They own the market now for both useage and application, and as noted from my first breakdown which ive copied below , they are a pure play on licensing , so back to the train - those getting off dont get it , those staying on do get it , those already on having a pretzel a hotdog and a beer have there feet up and are well in the know to what they do own.
Anyone that wishes to engage me - leave a message and lets exchange, re read my below posts for better feel of what we own here....ALL ABOARD!!
VDRM MUCH HIGHER $1.50 to $5.00 NEAR TERM
my analysis tells me that we might be headed higher alot higher starting very soon ( possibly this week )... let me tell you i own alot, lets say alot of stock here...so rest assured im not a pumper or a basher but feel its time to break my silence and spell out my reasoning to the board...
1) the technical are showing a perfect triangle pattern with a moving average about to swing to a huge buy signal, with .20 in site as high a while back that is the target to start
2) now lets get to the rub of it, the last time VDRM ran it ran to $5.00 with 75m shares outstanding giving it a 350m cap; so lets fast forward now with 226m outstanding $1.50 is the target here
3) if there is a secure partner as it looks after filings and coming to the end of the 6-9-12 month testing of the Tetrastem product we must all take a deep breathe of reality that the only competition sells the somewhat equivalent that take much longer to work at $500 a bottle vs VDRM $40 (avg)...in a market of 2.4b in the USA alone they will own the marketplace and with international brace yourself
4) with the pipeline of a potential TOPICAL viagra that alone is worth taking them out as they will be the disruptor in the marketplace and a target of $5.00 or 1b is reachable.
5) now break into the sales and earnings of on average a biotech and medical company of at least 3x - 5x and a run to a $10.00 level is quite attainable
so lets sum up:
.25 to .75 near term
1.50 target ( for inst'l and research and brokerage support with mutual funds )
5.00 target at 3x the baseline
10.00 expanded target once the street fully appreciates them and hospitals start using there product USA wide with the reduction of Obama care and the need to cut costs fro 500 to 40 or 85% discount!!
as mentioned im long alot here, and have other both within the group and outside the group...a brief history on my last pick last year was WATT wireless mobile and device charging from 4 to 20 and apple to step in soon enough so it will see 50
the similarities are supreme this is a pure play on licensing and that my friends is where it starts and ends...
VDRM MUCH HIGHER PART 2 (PHARMA ANALYSIS)
as noted above in my analysis which has been so kindly and appreciated to remain for the board to view at there leisure...
appreciate each market and research each company that presently controls each market PFE JNJ LLY MNKD BGEN AMGN and that VDRM is a pure play on licensing and patents which is brilliant in its own and is lead by people that understand this and appreciate so by controlling 75% of the outstanding stock here
lets break it down just a few sectors and make it a working model for all to add on to so the board is kept knowledge based for all
PFE Viagra is a category killer but it is a pill - and a pill is a introduction internally to the blood stream which out of fear a great portion of the population will just not take, now factor in a female Viagra alternative that is topical and replace the male Viagra with the same topical and its obvious that PFE will be forced to enter some sort of licensing agreement to hold onto there market share and as well look to capitalize on the female market as well ( m on f , and f on f ) there are those that will only use topical not internal
LLY and MNKD are the diabetic market and its huge - toenail fungal market - now add on a turnaround solution they have been needing for years, to treat at home foot infections ( home care largest market globally ) and that market alone is extraordinary with multiple companies all vying to be the dominant player and VDRM having the solution to license
JNJ marketplace is wounds - the band , now graduate it to the ability to speed the process up say 10 fold to heal any scrapes scratched wounds and to hold there market-share JNJ will be forced to enter some sort of licensing deal just to hold the line or risk crippling there empire quite easily
MRK and JNJ baldness market is in a level all itself, as its a do it yourself world we live in - add a just for men/ ladies crowd solution to expand into the baldness market and make that a CVS Walgreen's etc play for direct access more licensing
without even touching on the other markets there is exceptional growth here ( see my numbers post above that breaks the numbers down for all to see )
now lets sum it up with patent and licensing which is perfect, VDRM is already in the queue since 2014 to getting approved , have already done the 3-6-9-12 month studies with unreal results, and a new FDA will speed the process even faster come Jan 20th, also the MJ market CBDs will open up even more access, the population whole is more comfortable with topical that pills, and with VDRM technology all gets converted to topical from pills, so VDRM is the pure play licensing company to own...sales wise will be multiple billions 25b marketplace, and at 3 - 5x avg sales - the fundamentals are primed for a multi year movement...VDRM is a pure play on licensing....
PART 3 analysis will be upcoming soon - anyone that wishes to engage let me know and lets talk email or here
my suggestions are purely my own
